Skin

Polynucleotides

Injectable skin-quality treatments for the eyes, face or neck, with every plan tailored to the area being treated.

Clinical Introduction

Polynucleotides are injectable treatments used to support skin quality, including texture, fine lines, hydration and elasticity. They may be considered for the delicate eye area or for the face and neck. The eyes and the face or neck are assessed separately because the skin, concerns and treatment goals differ between these areas. Polynucleotides are not intended to create structural volume in the way that dermal fillers do. Improvements develop gradually, and individual response varies.

Eyes

The delicate eye area is assessed separately because fine skin, hollowness, pigmentation and fluid retention can create similar concerns but may require different approaches.

  • Supports the appearance of fine lines and crepey skin
  • May improve hydration and skin quality
  • May support elasticity in the delicate under-eye area
  • Can help the eye area appear fresher and less tired

Polynucleotides cannot correct every cause of dark circles, eye bags or under-eye hollowing. These concerns are assessed individually.

Face and Neck

The face and neck may be treated to support broader changes in skin quality. Each area is assessed and planned separately.

  • Supports the appearance of fine lines and uneven texture
  • May improve hydration and mild changes in elasticity
  • Can help dull or tired-looking skin appear fresher
  • Supports gradual improvement in overall skin quality

The face and neck are separate treatment areas, and the recommended product and course depend on clinical assessment.

Suitability Indicators

  • Adults seeking gradual improvement in skin quality
  • People concerned about fine lines, crepey texture or reduced hydration
  • Those who prefer a treatment that does not add structural volume
  • Patients whose concerns and medical history are suitable following assessment

Target Concerns

  • Fine lines and crepey skin around the eyes
  • Reduced hydration or elasticity
  • Uneven texture on the face or neck
  • Dull or tired-looking skin

Consultation Process

Your consultation includes a review of your medical history, allergies, current medicines, previous procedures and treatment goals. The eyes, face and neck are assessed as separate areas. We will discuss the product proposed, the recommended course, realistic outcomes, limitations, potential risks and alternative options.

The Treatment Journey Steps

  1. Face-to-face medical consultation and skin assessment
  2. Selection and preparation of the treatment area
  3. Careful placement using a series of small injections
  4. Assessment of the immediate skin response
  5. Personalised aftercare and follow-up advice

Safety & Downtime

Safety Note: Polynucleotide products differ in their composition and source, so relevant allergies and medical history must be reviewed before treatment. Risks can include swelling, bruising, tenderness, infection, inflammatory reactions and an unsatisfactory result. Rare or product-specific risks will be discussed during consultation.

Expected Downtime: Small raised areas or papules, redness, swelling, tenderness and bruising can occur after treatment. These effects usually begin to settle over the following days, although recovery varies and the eye area may swell more noticeably.

Clinical Benefits & Limitations

Primary Benefits

  • Supports gradual improvement in skin texture and hydration
  • May soften the appearance of fine lines and crepey skin
  • Allows the eyes and face or neck to be planned as distinct treatment areas
  • Does not add structural facial volume

Anatomical Limitations

  • Cannot correct every cause of dark circles, eye bags or under-eye hollowing
  • Results develop gradually and vary between individuals
  • A course of treatment may be recommended
  • The face and neck are separate treatment areas

Precautions & Contraindications

  • A relevant allergy to the proposed product or one of its components
  • Active infection, inflammation or broken skin in the treatment area
  • Pregnancy, breastfeeding or another medical reason identified during consultation
  • Any history or medicine that makes injectable treatment unsuitable

Home Aftercare Instructions

  • Follow the personalised aftercare instructions provided
  • Keep the treated area clean and avoid rubbing or firm pressure
  • Avoid make-up and active skincare for the period advised
  • Avoid strenuous exercise, alcohol and excessive heat as directed
  • Contact the clinic promptly if you experience concerning or worsening symptoms

When will I see the results?

Changes develop gradually rather than immediately. A course of treatment is commonly recommended, with improvements in skin quality becoming more noticeable over the following weeks and months. The degree and timing of response vary between individuals.

Frequently Asked Questions

Are polynucleotides the same as dermal filler?

No. Polynucleotides are used to support skin quality and are not intended to create the structural volume associated with dermal fillers.

Can polynucleotides remove dark circles?

Not all dark circles have the same cause. Pigmentation, visible blood vessels, shadowing, hollowing and fluid retention may all contribute, so the eye area must be assessed before any treatment is recommended.

Clinical Alternatives

Profhilo (where deep hydration and luminosity are the principal goals)

Explore clinical alternatives under professional direction.

Learn More →

Sunekos (where an amino-acid and hyaluronic-acid formulation may be more suitable)

Explore clinical alternatives under professional direction.

Learn More →

Tear Trough Filler (for selected structural under-eye hollowing after assessment)

Explore clinical alternatives under professional direction.

Learn More →

Related Treatments